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Hearing status in patients with rheumatoid arthritis 
 
Abstract 
Background: Previous studies showed that one of the complications of rheumatoid 
arthritis disease was auditory disorder. The goal of the present study was to compare the 
auditory status in patients with rheumatoid arthritis and healthy individuals. 
Methods: In the present case-control study, 30 normal persons and 60 persons with 
rheumatoid arthritis with mean age of 46.72 and standard deviation of 6.76 of both genders 
were appraised using pure tone audiometry, tympanometry and speech audiometry. The 
mean disease duration in patients with rheumatoid arthritis was 12.51±6.09 years. 
Results: The frequency of hearing loss in rheumatoid arthritis group was significantly 
more than the control group (p=0.001). All patients had sensorineural hearing loss. Only in 
5% of rheumatoid arthritis group, abnormal tympanometry (as type) was reported. Speech 
discrimination score analysis showed significant difference between the patients with 
rheumatoid arthritis and controls. In terms of hearing threshold level, the mean hearing 
threshold level (in 2000, 4000 and 8000 Hz frequencies) of the patients with rheumatoid 
arthritis was significantly higher than control group in both ears (p<0.05). A positive 
significant correlation was found among mean hearing threshold level in 4000 and 8000 
Hz frequencies and rheumatoid arthritis duration in both ears. 
Conclusion: The frequency of hearing loss and the average hearing threshold in RA 
patients were higher than healthy individuals. The most common type hearing loss is 
sensorineural. 
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Rheumatoid arthritis (RA) is a systemic long-lasting inflaming illness that impacts 
roughly 1% of the global people and is specified by fervor of the synovial coats of 
diarthrodial joints, which result in oncoming demolition of articular and periarticular 
textures (1-3). It is accompanied with oncoming inability, systemic difficulties, timely 
death and socioeconomic expenses(4, 5). RA may entail alternative body systems 
containing heart, lung, skin, and eye (6, 7). In this regard, the possibility of auditory 
system contention in RA has been one of the domains with great concern. Raut et al. 
(2001) contrasted 35 patients with RA with 35 age- and sex-matched controls to assess the 
relation between RA and hearing disability (8). The finding revealed a considerable 
hearing disability at 500 Hz, 1.0 kHz, and 2.0 kHz in patients with RA (8). Ozcan et al. 
(2002) completed a controlled study to investigate the outbreak of hearing loss in RA (9). 
Their study recorded that the outbreak of hearing impairment was considerably higher in 
patients with RA(9). Halligan et al. (2006) performed a case‐control cross‐sectional study 
of 29 patients with RA with illness period more than 5 years to measure if patients with 
rheumatoid arthritis (RA) are more presumably to possess subclinical hearing loss 
contrasted to individuals deprived of RA (10). 
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According to the results, individuals with RA did not 
display any objective hearing threshold dissimilarity from 
subjects deprived of RA (10). However, in general the 
auditory system is negatively affected in patients with RA, 
but the specifications of the hearing impairment (HI) are 
insignificantly realized until now. Both sensorineural hearing 
loss (SNHL), conductive hearing loss (CHL) and or mixed 
type have been recorded. Currently, the pathogenesis of 
hearing disability in RA is not distinctly recognized (11). 
Nevertheless, the incudostapedial and incudomalleolar joints 
involvement by the similar inflammatory and ruinous 
modifications as another joint, could make CHL and the 
inner ear lesion because of vasculitis or neuritis, or the 
ototoxicity of antirheumatic drugs used for RA treatment 
leading to SNHL(12-14).  
Since the relationship among RA and hearing impairment 
is as again argumentative(1, 15, 16) and just a little 
systematic inquiries have contrasted the proficiency and 
feasible impairment of the auditory system in patients with 
RA, so the goal of present study was to specify and compare 
hearing impairment in these group of patients and healthy 
controls employing pure tone audiometry (PTA), speech 
audiometry and tympanometry.  
On the other hand, in this study with the establishment of 
age limits, the elimination of presbycusis was achieved for 
the first time in Iran.   
 
 
Methods 
In this study, based on previous similar study, 30 normal 
individuals and 60 patients with RA were evaluated. Normal 
individuals and patients with RA were selected from cases 
attending a rheumatology clinic at Ayatollah Rouhani 
Hospital, Babol. 
The patients with RA were  not included in the study if 
there was any history of hearing aid use, familial hearing 
loss, neurological problems, congenital head and neck 
anomalies, convulsions, epilepsy, head trauma, ototoxic 
medications, brain surgery and RA more than 5 years 
according to medical records. In an age-matched control 
group, besides the mentioned items, absence of RA was also 
confirmed by a skilled rheumatologist. All patients and 
volunteers gave informed consent and this research was 
conducted with the approval of the Ethics Committee of 
Babol University of Medical Sciences. First, a 
comprehensive case history was gathered by an expert 
researcher via a definite questionnaire, covered the 
demographic, socioeconomic and clinical specifications of 
the study population, in the Otolaryngology Clinic of 
Ayatollah Rouhani Hospital. Then a thorough ENT 
inspection was done for every contributor with specific stress 
on hearing discontents. Otoscopic inspection was performed 
to examine the ear canal, cerumen, and healthy eardrum at 
the Otolaryngology Clinic of Ayatollah Rohani Hospital. If 
there was a cerumen, cleansing was done. Then audiological 
valuation was carried out in a sound-proof room and 
included evaluation of pure tone audiometry, speech 
audiometry and tympanometry was applied to all patients 
and controls via skilled audiologist who was sightless to the 
study group contributor.  
Pure tone audiometry was performed to check each 
person’s hearing status at frequencies of 250,500, 1000, 
2000, 4000 and 8000 Hz using an ASTRA audiometer and 
TDH39 headphone. Hearing was accepted as abnormal if the 
hearing threshold was higher than 20 dB at each frequency. 
Speech audiometry included SRT and SDS using dissyllabic 
and monosyllabic words respectively, was also 
performed/evaluated.  
Tympanometric tests were performed to determine 
tympano-ossicular chain compliance and middle-ear pressure 
with a Zodiac (Madsen) impedance audiometer at a probe 
tone frequency of 226 Hz. Statistical analysis was conducted 
by SPSS 18 statistical software at significance level of 
p<0.05. Since the data distribution was normal, Pearson 
correlation coefficient, one way ANOVA, t-test and chi 
square were used for statistical analysis.  
 
Results 
Our study was conducted on 60 patients with RA (55 
females and 5 males) with a mean age of 47.20 and standard 
deviation of 7.43 and 30 normal individuals (24 females and 
6 males) with mean age of 45. 76 and standard deviation of 
5.17 years, aged between 18-60   years. 
The basic information of the control group and the group 
of people with RD showed frequency of hearing loss in  
rheumatoid arthritis group was significantly more than the 
control group (p=0.001) and all of whom showed a SNHL. 
The mean threshold value for both ears of the patients with 
RA and the controls were compared (table 1).  
A statistically significant difference was found between 
the average of hearing thresholds of both ears in the two 
groups. 
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Table 1. Comparison of the mean threshold value in 
patients with RA and the controls in the right and left ears. 
P value Control 
(mean±SD) 
RA 
(mean±SD) 
Frequency 
0.22 
0.09 
0.1 
0.002 
0.002 
0.001 
6.33±3.92 
7.33±3.40 
9.0±3.05 
11.16±3.95 
11.1±4.08 
13.3±6.47 
7.40±3.67 
8.70±3.47 
10.30±3.69 
14.1±7.86 
16.9±11.24 
23±16.51 
250 
500 
1000 
2000 
4000 
8000 
In 3 (5%) patients of the RA group, an As-type 
tympanogram (Reduced mobility of the tympanic membrane 
caused by a stiffened middle ear system can cause a shallow 
peak on the tympanogram, called a Type As tympanogram) 
was observed, 2 of whom showed bilateral As type, whereas 
1 patient showed a unilateral as type. All persons in the 
control group showed normal tympanogram. As shown in 
table 2, a positive significant correlation was found among 
disease duration and mean hearing threshold value in both 
ears at 4000Hz and 8000Hz. 
Table 2. Assessing the correlation among disease 
duration and mean hearing threshold value in both ears 
Hearing threshold RA 
duration              8000 4000 2000 1000 500 250
0.300 
0.03* 
0.349 
0.01* 
0.204 
0.15 
0.203 
0.15 
0.272 
0.06 
0.182 
0.20 
r 
Pvalue 
Right 
ear 
0.294 
0.03* 
0.295 
0.03* 
0.256 
0.07 
0.218 
0.12 
0.096 
0.50 
0.174 
0.22 
r 
Pvalue 
Left ear 
RA (rheumatoid arthritis) 
Table 3 shows the mean and standard deviation of SDS 
and SRT values for both ears of the control group and the 
group of people with RD. These results revealed no statistically 
significant difference between the average of SRT values of 
both ears of persons in RA and control groups. While a 
statistically significant difference was noted for mean SDS 
values in both ears between the patients with RA and controls. 
Table 3. Descriptive statistics of SDS and SRT values in 
control group and the group of people with RD 
P-
value 
Control RA 
Speech 
audiometry 
Variable 
0.08 
0.03 
10.34±3.26 
96.07±3.29 
14.28±5.83 
93.56±4.69 
SRT 
SDS 
Right ear 
 
0.17 
0.04 
10.63±3.65
95.84±3.62 
13.02±6.1393.
28±3.46 
SRT 
SDS 
Left ear 
SRT (speech recognition threshold)        SDS (speech discrimination score) 
RA (rheumatoid arthritis) 
Discussion 
This study has shown a higher spread of hearing loss, 
particularly sensorineural kind, in RA patients. Our data 
were in line with those of the prior search that demonstrated 
subjects with RA have more presumably possess a 
SNHL(13, 17-24).nonetheless, Rosenberg et al. (1978) could 
not detect any degree of relation among RA and hearing 
loss(25). In determining the correlation between RA disease 
duration and hearing impairments, a positive significant 
correlation was found among disease duration and mean 
hearing threshold value in both ears at 4000Hz and 8000Hz. 
Ozturk et al. (2004) and Dikici et al. (2009) studies also 
concurred with the detection of the present study and 
demonstrated that hearing impairment progressed with the 
duration of  the disease (11, 13). In 2011, Arslan et al. 
examined the relation between incidence of hearing loss and 
duration of disease in 44 RA patients with mean age of  
47.2±11.2(26). The results of this study showed no relation 
between the incidence of hearing loss and duration of 
disease(26). In 2016, Vega et al. investigated hearing in RA 
population(12). They carried out their study on fifty-three 
patients with rheumatoid arthritis and 71 patients with an 
indigenous condition of health who were matched for age 
and gender(12). In their study, no correlation was found 
between those diagnosed with SNHL using PTA and the 
duration of the disease(12). These inconsistencies may be 
due to the differences in the characteristics of studied 
subjects.  
We showed the type A tympanogram only in 5% of 
patients. Our results are similar to Gonzalez et al. (2015) , 
Lobo et al. (2016) , Rahne et al. (2017) , Galarza-Delgado et 
al. (2017) and Ahmadzade et al.’s (2017) studies which 
demonstrated no significant difference between the stiffness 
of ossicular chains and RA(15, 27-30) .In 2011, Arslan et al. 
compared 44 RA patients with 44 voluntary healthy 
controls(26). The results of this study showed that there were 
significant differences among the two studied groups in 
terms of Type A tympanogram (26). Takatsu et al. (2005) 
evaluated the degree of hearing impairment in patients with 
rheumatoid arthritis (RA) (2). The findings of this study 
showed the type- A tympanogram significantly increased in 
the patients with RA compared with the controls (2). Ozcan 
et al. (2002) investigated hearing and middle ear functions in 
37 patients with RA and 35 controls to study the prevalence 
and the nature of hearing loss in RA (9). The results of this 
study showed higher prevalence of abnormal tympanogram 
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in RA patients (9). In 1980, Reiter et al. measured  the 
middle ear immittance in RA patients (31). In their study, 
immittance data  disclosed abnormal discoveries in 59% of 
the patients (31). The discrepancies between these findings 
may be due to differences in the mean age and the number of 
samples. In the present study, the relation between speech 
reception threshold and RA and the findings showed that this 
test has failed to separate patients with RA from controls. On 
the other hand, in this study a statistically significant 
difference was noted for mean SDS values in both ears 
between the patients with RA and controls. So it can be 
supposed that the disease process touched beyond the 
cochlea. Unlike the present study, Ozcan et al. , Raut et al. 
and Ahmadzade et al.’s study results showed no statistically 
significant difference between the two groups in terms of 
mean SDS values (9, 20, 28). According to Galarza-Delgado 
et al.’s studies in 2017, RA subjects recognized >70% of the 
monosyllabic and trisyllabic words in speech audiometry 
(29). More studies are needed to clear the difference. For 
future researches, we recommend that the patients' auditory 
status should be compared in active and passive phases of 
the disease. 
In conclusion the present study showed that the 
frequency of hearing loss in rheumatoid arthritis group was 
significantly more than the control group. Accordingly, 
audiological assessment should be considered in routine 
evaluation of patients with RA, to prevent hearing-related 
handicap.  
 
 
Acknowledgments 
This article is an approved project of Babol University of 
Medical Sciences with contract number 2219. We would like 
to acknowledge the Rehabilitation Research Center and 
Ayatollah Rouhani Hospital of Babol for their utmost help 
with the project. 
Conflicts of interest: The author's declare that they have no 
competing interest. 
 
 
References 
1. Yildirim A, Surucu G, Dogan S, Karabiber M. 
Relationship between disease activity and hearing 
impairment in patients with rheumatoid arthritis 
compared with controls. Clin Rheumatol 2016; 35: 309-
14. 
2. Takatsu M, Higaki M, Kinoshita H, Mizushima Y, 
Koizuka I. Ear involvement in patients with rheumatoid 
arthritis. Otol Neurotol 2005; 26: 755-61. 
3. Emamifar A, Hansen IMJ. An update on hearing 
impairment in patients with rheumatoid arthritis. J Otol 
2018; 13: 1-4. 
4. Jeong H, Chang YS, Baek SY, et al. Evaluation of 
audiometric test results to determine hearing impairment 
in patients with rheumatoid arthritis: analysis of data 
from the Korean National Health and Nutrition 
Examination Survey. PloS One 2016; 11: e0164591. 
5. Firestein GS. Evolving concepts of rheumatoid arthritis. 
Nature 2003; 423: 356-61. 
6. McInnes IB, Schett G. The pathogenesis of rheumatoid 
arthritis. New Engl J Med 2011; 365: 2205-19. 
7. Huang CM, Chen HJ, Huang PH, et al. Retrospective 
cohort study on risk of hearing loss in patients with 
rheumatoid arthritis using claims data. BMJ Open 2018; 
8: e018134. 
8. Raut VV, Cullen J, Cathers G. Hearing loss in rheumatoid 
arthritis. J Otolaryngol 2001; 30: 289-94. 
9. Özcan M, Karakuş FM, Gündüz O, Tuncel Ü, Şahin H. 
Hearing loss and middle ear involvement in rheumatoid 
arthritis. Rheumatol Int 2002; 22: 16-9. 
10. Halligan CS, Bauch CD, Brey RH, et al. Hearing loss in 
rheumatoid arthritis. Laryngoscope 2006; 116: 2044-9. 
11. Ozturk, A, Yalcin, S, Kaygusuz, I, et al. High-frequency 
hearing loss and middle ear involvement in rheumatoid 
arthritis. Am J Otolaryngol 2004; 25: 411-7. 
12. Lasso de la Vega M, Villarreal IM, Lopez-Moya J, 
Garcia-Berrocal JR. Examination of hearing in a 
rheumatoid arthritis population: role of extended-high-
frequency audiometry in the diagnosis of subclinical 
involvement. Scientifica 2016; 2016: 571383. 
13. Dikici O, Muluk NB, Tosun AK, Unlusoy I. Subjective 
audiological tests and transient evoked otoacoustic 
emissions in patients with rheumatoid arthritis: analysis 
of the factors affecting hearing levels. Eur Arch 
Otorhinolaryngol 2009; 266: 1719-26. 
14. Seçkin Ü, Özoran K, Ikinciogullari A, Borman P, Bostan 
EE. Hydroxychloroquine ototoxicity in a patient with 
rheumatoid arthritis. Rheumatol Int 2000; 19: 203-4. 
15. Lobo FS, Dossi MO, Batista L, Shinzato MM. Hearing 
impairment in patients with rheumatoid arthritis: 
association with anti-citrullinated protein antibodies. Clin 
Rheumatol 2016; 35: 2327-32. 
 Caspian J Intern Med 2019; 10(4):447-451  
Hearing status in patients with rheumatoid arthritis                                                          451 
16. Salvinelli F, Cancilleri F, Casale M, et al. Hearing 
thresholds in patients affected by rheumatoid arthritis. 
Clin Otolaryngol Allied Sci 2004; 29: 75-9. 
17. Kastanioudakis I, Skevas A, Danielidis V, et al. Inner ear 
involvement in rheumatoid arthritis: a prospective 
clinical study. J Laryngol Otol 1995; 109: 713-8. 
18. Garcia Callejo FJ, Conill Tobias N, Munoz Fernandez N, 
et al. Hearing impairment in patients with rheumatoid 
arthritis. Acta Otorrinolaringol 2007; 58: 232-8. 
19. Magaro M, Zoli A, Altomonte L, et al. Sensorineural 
hearing loss in rheumatoid arthritis. Clin Exp Rheumatol 
1990; 8: 487-90. 
20. Raut VV, Cullen J, Cathers G. Hearing loss in 
rheumatoid arthritis. J Otolaryngol 2001; 30: 289-94. 
21. Pascual-Ramos V, Contreras-Yáñez I, Enríquez L, 
Valdés S, Ramírez-Anguiano J. Hearing impairment in a 
tertiary-care-level population of Mexican rheumatoid 
arthritis patients. J Clin Rheumatol 2012; 18: 393-8. 
22. Elwany S, el Garf A, Kamel T. Hearing and middle ear 
function in rheumatoid arthritis. J Rheumatol 1986; 13: 
878-81. 
23. Reiter D, Konkle DF, Myers AR, Schimmer B, Sugar JO. 
Middle ear immittance in rheumatoid arthritis. Arc 
Otolaryngol 1980; 106: 114-7. 
24. Pascual-Ramos V, Contreras-Yanez I, Rivera-Hoyos P, 
Enriquez L, Ramirez-Anguiano J. Cumulative disease 
activity predicts incidental hearing impairment in patients 
with rheumatoid arthritis (RA). Clin Rheumatol 2014; 
33: 315-21. 
25. Rosenberg JN, Moffat DA, Ramsden RT, Gibson WP, 
Booth JB. Middle ear function in rheumatoid arthritis. 
Ann Rheumatic Dis 1978; 37: 522-4. 
26. Arslan N, Cicek Y, Islam A, et al. Involvement of ear in 
rheumatoid arthritis. Prospective Clinical Study. Int Adv 
Otol 2011; 7: 208-14. 
27. Rahne T, Clauß F, Plontke SK, Keyßer G. Prevalence of 
hearing impairment in patients with rheumatoid arthritis, 
granulomatosis with polyangiitis (GPA, Wegener’s 
granulomatosis), or systemic lupus erythematosus. Clin 
Rheumatol 2017; 36: 1501-10. 
28. Ahmadzadeh A, Daraei M, Jalessi M, et al. Hearing 
status in patients with rheumatoid arthritis. J Laryngol 
Otol 2017; 131: 895-9. 
29. Galarza-Delgado DA, Villegas Gonzalez MJ, Riega 
Torres J, et al. Early hearing loss detection in rheumatoid 
arthritis and primary Sjogren syndrome using extended 
high frequency audiometry. Clin Rheumatol 2018; 37: 
367-73. 
30. Treviño-González JL, Villegas-González MJ, Muñoz-
Maldonado GE, et al. Subclinical sensorineural hearing 
loss in female patients with rheumatoid arthritis. Cir Cir 
2015; 83: 364-70. 
31. Reiter D, Konkle DF, Myers AR, Schimmer B, Sugar JO. 
Middle ear immittance in rheumatoid arthritis. Arch 
Otolaryngol 1980; 106: 114-7. 
 
